查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678521

氣霧劑給藥裝置市場規模、佔有率、趨勢分析報告：按類型、應用、分銷管道、地區和細分市場預測，2025-2030 年

Aerosol Drug Delivery Devices Market Size, Share & Trends Analysis Report By Type (Inhaler, Nebulizer), By Application (COPD, Asthma, Cystic Fibrosis), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

氣霧劑給藥裝置市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球氣霧劑藥物輸送設備市場預計到 2030 年將達到 621 億美元。

預計 2025 年至 2030 年間，市場將以 13.16% 的顯著複合年成長率擴張。推動市場成長的關鍵因素包括呼吸系統疾病盛行率的上升、醫療意識的增強、吸入器技術的進步以及家庭治療的需求不斷成長。

市場成長的動力在於慢性阻塞性肺病、氣喘和囊腫纖維化等呼吸系統疾病的盛行率不斷上升，對攜帶式吸入設備的關注度不斷提高，以及對快速有效治療的需求。其他因素包括政府宣傳宣傳活動、人口老化、技術進步、設備採用率提高、都市化、污染、研發增加。

進入市場的創新專注於開發環保燃料、改進用戶介面設計以提高患者依從性以及利用人工智慧進行個人化診斷和治療。生物分解性材料的研究可能為設備建造提供永續的替代方案。市場競爭激烈且分散，技術的快速進步推動著不斷的變化。公司正積極順應潮流，透過專注於以患者為中心和環保的解決方案來抓住成長機會。

此外，阿普塔集團 (AptarGroup, Inc.)、荷蘭皇家飛利浦公司 (Koninklijke Philips NV)、阿斯特捷利康 (AstraZeneca) 和諾華公司 (Novartis AG) 等主要企業正在採取合作、研究合作、新產品發布、收購和業務擴展等戰略舉措，以加強其市場地位。例如，2024年1月，Kindeva Drug Delivery宣布收購專門從事鼻腔給藥的公司Summit Biosciences。

鼻腔給藥正在成為許多適應症的首選給藥方式，因為它允許在急性和緊急情況下進行非侵入性藥物給藥。 高峰會對如何有效配製鼻腔給藥藥物以及進行商業規模生產的能力有著獨特的理解。此次收購不僅符合 Kindeva 成為藥物-設備組合 CDMO 市場全球領導者的雄心，而且還擴展了公司可為全球客戶提供的工具箱，以幫助改善患者的治療效果和治療體驗。

Kindeva 執行長 Milton Boyer

氣霧劑藥物輸送設備市場報告重點

  • 根據產品類型，吸入器市場預計將在 2024 年佔據市場主導地位，收益佔有率為 89.59%，並且預計在預測期內以最快的複合年成長率成長，這得益於技術先進產品的不斷發展和醫療保健領域數字解決方案的不斷採用。
  • 根據應用，COPD 領域預計將在 2024 年佔據最大的市場佔有率，並且由於全球盛行率上升，預計在預測期內將成長最快。
  • 根據分銷管道，由於大宗藥品分銷需求的不斷成長和呼吸系統疾病患者人數的不斷增加，機構藥房部門將在 2024 年佔據最大的市場佔有率。
  • 北美佔據氣霧劑藥物輸送設備產業的主導地位，2024 年的市場佔有率為 39.49%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章。氣霧劑藥物輸送裝置市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 產業分析
    • 使用者觀點分析
    • 主要最終用戶
  • 技術展望
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰與機會分析
  • 氣霧劑給藥裝置市場分析工具
    • 波特的分析
    • PESTEL 分析
  • COVID-19 的影響

4. 氣霧劑給藥裝置市場類型、估計與趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年按類型分類的市場佔有率分析
  • 細分儀表板
  • 2018 年至 2030 年氣霧劑給藥裝置市場（按類型）
    • 噴霧器
    • 吸入器

5. 氣霧劑給藥裝置市場：按應用分類的估計和趨勢分析

  • 定義和範圍
  • 2024 年和 2030 年應用市場佔有率分析
  • 細分儀表板
  • 氣霧劑給藥裝置市場（按應用分類），2018 年至 2030 年
    • 氣喘
    • 慢性阻塞性肺病（COPD）

6. 氣霧劑給藥裝置市場按分銷管道分類的預測和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年通路市場佔有率分析
  • 細分儀表板
  • 2018 年至 2030 年氣霧劑給藥裝置市場（依通路分類）
    • 零售藥局
    • 醫療機構藥房
    • 網路藥局

第7章氣霧劑給藥裝置市場：區域、類型、應用和分銷管道估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場概況
  • SWOT 分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 氣霧劑藥物輸送設備市場佔有率（按地區分類），2024 年和 2030 年，百萬美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的近期趨勢及影響分析
  • 公司分類
  • 公司市場佔有率分析
  • 公司熱圖分析
  • 戰略地圖
    • 擴張
    • 合併和收購
    • 夥伴關係和合作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • AptarGroup, Inc.
    • Koninklijke Philips NV
    • AstraZeneca
    • Novartis AG
    • Sanofi
    • OMRON Corporation
    • Medline Industries, LP.
    • GF Health Products, Inc.
    • DRIVE MEDICAL GMBH & CO. KG
    • Teva Pharmaceutical Industries Ltd
    • Aerogen（Stamford Devices Limited Group）
    • Sensirion AG
    • PARI Respiratory Equipment, Inc.
    • Catalent, Inc
    • Pfizer Inc.
    • Beurer GmbH
Product Code: GVR-4-68040-505-5

Aerosol Drug Delivery Devices Market Growth & Trends:

The global aerosol drug delivery devices market size is anticipated to reach USD 62.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 13.16% from 2025 to 2030. Major factors driving the market growth include the rising prevalence of respiratory diseases, increasing healthcare awareness, advancements in inhaler technology, and the growing demand for home-based treatments.

The market growth is driven by the increasing prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis, a growing focus on portable inhalation devices, and the need for quick, effective treatments. Other factors include government awareness campaigns, an aging population, technological advancements, higher device adoption, urbanization, pollution, and increased R&D.

Innovation in the market focuses on developing eco-friendly fuels, improving user-interface designs for better patient adherence, and using AI for personalized diagnostics and treatment. Research into biodegradable materials could provide sustainable alternatives for device construction. The market is competitive and fragmented, with rapid technological progress driving constant change. Companies proactively embrace trends, focusing on patient-centered, environmentally friendly solutions to seize growth opportunities.

Moreover, key players in the market, such as AptarGroup, Inc., Koninklijke Philips N.V., AstraZeneca, and Novartis AG, among others, are engaging in strategic initiatives such as partnerships, collaborations, new product launches, acquisitions, and expansions to strengthen their market position. For instance, in January 2024, Kindeva Drug Delivery announced the acquisition of Summit Biosciences, a company specializing in intranasal drug delivery.

"Nasal drug delivery is becoming a preferred dosage format for a growing number of indications, as it allows users to non-invasively administer medications in an acute or emergency setting. Summit brings a differentiated understanding of how to effectively formulate drugs for nasal delivery and the capability to manufacture them at commercial scale. This addition not only fits Kindeva's ambition to be a global leader in the drug-device combination products CDMO market but also expands the toolbox we can offer our customers to help improve patient outcomes and experience of care globally."

Kindeva CEO Milton Boyer.

Aerosol Drug Delivery Devices Market Report Highlights:

  • Based on type, the inhaler segment dominated the market with a revenue share of 89.59% in 2024 and is expected to witness the fastest growth at a CAGR over the forecast period owing to the advancement the development of technologically advanced products, and the growing adoption of digital solutions in the healthcare sector.
  • Based on application, the COPD segment held the largest market share in 2024 and is anticipated to be the fastest-growing segment over the forecast period owing to the rising increasing prevalence worldwide.
  • Based on the distribution channel, the institutional pharmacies segment held the largest market share in 2024, driven by the increasing need for bulk medication distribution, and the expanding patient population with respiratory conditions.
  • North America dominated the aerosol drug delivery devices industry with a market share of 39.49% in 2024, owing to the advanced healthcare infrastructure, increasing geriatric population, and technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
      • 1.7.1.2. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Aerosol Drug Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising prevalence of respiratory diseases
      • 3.5.1.2. Technological advancements
      • 3.5.1.3. Rising geriatric population
      • 3.5.1.4. Increasing awareness of self-medication and home healthcare
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. High cost of devices
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Aerosol Drug Delivery Devices Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal Landscape
  • 3.7. Impact of COVID-19

Chapter 4. Aerosol Drug Delivery Devices Market: Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Aerosol Drug Delivery Devices Market: By Type, 2018 to 2030
    • 4.4.1. Nebulizers
      • 4.4.1.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. Jet
        • 4.4.1.2.1. Jet Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.3. Mesh
        • 4.4.1.3.1. Mesh Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.4. Active
        • 4.4.1.4.1. Active Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.5. Passive
        • 4.4.1.5.1. Passive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.6. Ultrasonic
        • 4.4.1.6.1. Ultrasonic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Inhaler
      • 4.4.2.1. Inhaler Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Pressurized Metered-Dose Inhaler (PMDI)
        • 4.4.2.2.1. Pressurized Metered-Dose Inhaler (PMDI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Dry-Powder Inhaler (DPI)
        • 4.4.2.3.1. Dry-Powder Inhaler (DPI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Aerosol Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Aerosol Drug Delivery Devices Market: By Application, 2018 to 2030
    • 5.4.1. Asthma
      • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Chronic Obstructive Pulmonary Disease (COPD)
      • 5.4.2.1. Chronic Obstructive Pulmonary Disease (COPD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Aerosol Drug Delivery Devices Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Distribution Channel Market Share Analysis, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Aerosol Drug Delivery Devices Market: By Distribution Channel, 2018 to 2030
    • 6.4.1. Retail Pharmacies
      • 6.4.1.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Institutional Pharmacies
      • 6.4.2.1. Institutional Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Online Pharmacies
      • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Aerosol Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Region, Type, Application, Distribution Channel

  • 7.1. Definition and Scope
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Regional Market Snapshot
  • 7.5. SWOT Analysis
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East & Africa
  • 7.6. Aerosol Drug Delivery Devices Market Share, By Region, 2024 & 2030, USD Million
  • 7.7. North America
    • 7.7.1. North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Mexico
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.4.3. Competitive Insights
      • 7.7.4.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Europe
    • 7.8.1. Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. UK
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. France
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. France Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.6.3. Competitive Insights
      • 7.8.6.4. Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.7. Sweden
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.7.3. Competitive Insights
      • 7.8.7.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.8. Denmark
      • 7.8.8.1. Key Country Dynamics
      • 7.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.8.3. Competitive Insights
      • 7.8.8.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.9. Norway
      • 7.8.9.1. Key Country Dynamics
      • 7.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.9.3. Competitive Insights
      • 7.8.9.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. China
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.2.3. Competitive Insights
      • 7.9.2.4. China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Japan
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.3.3. Competitive Insights
      • 7.9.3.4. Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. India
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.4.3. Competitive Insights
      • 7.9.4.4. India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. South Korea
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.5.3. Competitive Insights
      • 7.9.5.4. South Korea Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.6. Australia
      • 7.9.6.1. Key Country Dynamics
      • 7.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.6.3. Competitive Insights
      • 7.9.6.4. Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.7. Thailand
      • 7.9.7.1. Key Country Dynamics
      • 7.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.7.3. Competitive Insights
      • 7.9.7.4. Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Latin America
    • 7.10.1. Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.2.3. Competitive Insights
      • 7.10.2.4. Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.3. Argentina
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.3.3. Competitive Insights
      • 7.10.3.4. Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11. Middle East and Africa
    • 7.11.1. Middle East and Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. Key Country Dynamics
      • 7.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.2.3. Competitive Insights
      • 7.11.2.4. South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.3. Saudi Arabia
      • 7.11.3.1. Key Country Dynamics
      • 7.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.3.3. Competitive Insights
      • 7.11.3.4. Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.4. UAE
      • 7.11.4.1. Key Country Dynamics
      • 7.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.4.3. Competitive Insights
      • 7.11.4.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.5. Kuwait
      • 7.11.5.1. Key Country Dynamics
      • 7.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.5.3. Competitive Insights
      • 7.11.5.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
  • 8.6. Company Profiles
    • 8.6.1. AptarGroup, Inc.
      • 8.6.1.1. Participant's Overview
      • 8.6.1.2. Financial Performance
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Recent Developments
    • 8.6.2. Koninklijke Philips N.V.
      • 8.6.2.1. Participant's Overview
      • 8.6.2.2. Financial Performance
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Recent Developments
    • 8.6.3. AstraZeneca
      • 8.6.3.1. Participant's Overview
      • 8.6.3.2. Financial Performance
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Recent Developments
    • 8.6.4. Novartis AG
      • 8.6.4.1. Participant's Overview
      • 8.6.4.2. Financial Performance
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Recent Developments
    • 8.6.5. Sanofi
      • 8.6.5.1. Participant's Overview
      • 8.6.5.2. Financial Performance
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Recent Developments
    • 8.6.6. OMRON Corporation
      • 8.6.6.1. Participant's Overview
      • 8.6.6.2. Financial Performance
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Recent Developments
    • 8.6.7. Medline Industries, LP.
      • 8.6.7.1. Participant's Overview
      • 8.6.7.2. Financial Performance
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Recent Developments
    • 8.6.8. GF Health Products, Inc.
      • 8.6.8.1. Participant's Overview
      • 8.6.8.2. Financial Performance
      • 8.6.8.3. Product Benchmarking
      • 8.6.8.4. Recent Developments
    • 8.6.9. DRIVE MEDICAL GMBH & CO. KG
      • 8.6.9.1. Participant's Overview
      • 8.6.9.2. Financial Performance
      • 8.6.9.3. Product Benchmarking
      • 8.6.9.4. Recent Developments
    • 8.6.10. Teva Pharmaceutical Industries Ltd
      • 8.6.10.1. Participant's Overview
      • 8.6.10.2. Financial Performance
      • 8.6.10.3. Product Benchmarking
      • 8.6.10.4. Recent Developments
    • 8.6.11. Aerogen (Stamford Devices Limited Group)
      • 8.6.11.1. Participant's Overview
      • 8.6.11.2. Financial Performance
      • 8.6.11.3. Product Benchmarking
      • 8.6.11.4. Recent Developments
    • 8.6.12. Sensirion AG
      • 8.6.12.1. Participant's Overview
      • 8.6.12.2. Financial Performance
      • 8.6.12.3. Product Benchmarking
      • 8.6.12.4. Recent Developments
    • 8.6.13. PARI Respiratory Equipment, Inc.
      • 8.6.13.1. Participant's Overview
      • 8.6.13.2. Financial Performance
      • 8.6.13.3. Product Benchmarking
      • 8.6.13.4. Recent Developments
    • 8.6.14. Catalent, Inc
      • 8.6.14.1. Participant's Overview
      • 8.6.14.2. Financial Performance
      • 8.6.14.3. Product Benchmarking
      • 8.6.14.4. Recent Developments
    • 8.6.15. Pfizer Inc.
      • 8.6.15.1. Participant's Overview
      • 8.6.15.2. Financial Performance
      • 8.6.15.3. Product Benchmarking
      • 8.6.15.4. Recent Developments
    • 8.6.16. Beurer GmbH
      • 8.6.16.1. Participant's Overview
      • 8.6.16.2. Financial Performance
      • 8.6.16.3. Product Benchmarking
      • 8.6.16.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 4 North America aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Canada aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 19 UK aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 20 UK aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 Germany aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 22 Germany aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 France aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 25 France aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 France aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Italy aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 28 Italy aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 Italy aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Spain aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 31 Spain aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 32 Spain aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Sweden aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 34 Sweden aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 35 Sweden aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Denmark aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 37 Denmark aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Norway aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 40 Norway aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 41 Norway aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Japan aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 46 Japan aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 China aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 49 China aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 50 China aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 India aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 52 India aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 India aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Australia aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 55 Australia aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 56 Australia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 57 South Korea aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 59 Thailand aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Latin America aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Brazil aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 66 Brazil aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 67 Brazil aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 68 Argentina aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 69 Argentina aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 70 Argentina aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 MEA aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 72 MEA aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 73 MEA aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 74 South Africa aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 75 South Africa aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 76 South Africa aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 80 UAE aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 81 UAE aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 82 UAE aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 83 Kuwait aerosol drug delivery devices market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 84 Kuwait aerosol drug delivery devices market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 85 Kuwait aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Aerosol Drug Delivery Devices Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Aerosol Drug Delivery Devices- Market Size and Growth Prospects (USD Million)
  • Fig. 12 Aerosol Drug Delivery Devices Market: Industry Value Chain Analysis
  • Fig. 13 Aerosol Drug Delivery Devices Market: Market Dynamics
  • Fig. 14 Aerosol Drug Delivery Devices Market: PORTER's Analysis
  • Fig. 15 Aerosol Drug Delivery Devices Market: PESTEL Analysis
  • Fig. 16 Aerosol Drug Delivery Devices Market: Type movement analysis, 2018-2030 (USD Million)
  • Fig. 17 Aerosol Drug Delivery Devices Market Share Analysis by Type, 2024 & 2030
  • Fig. 18 Nebulizers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Jet Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Mesh Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Active Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 22 Passive Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 Ultrasonic Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Inhaler Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Pressurized Metered-Dose Inhaler (PDMI) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 26 Dry-Powder Inhaler (DPI) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 27 Aerosol Drug Delivery Devices Market: Application movement analysis, 2018-2030 (USD Million)
  • Fig. 28 Aerosol Drug Delivery Devices Market Share Analysis by Application , 2024 & 2030
  • Fig. 29 Asthma Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Chronic Obstructive Pulmonary Disease (COPD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 31 Cystic Fibrosis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 32 Other (Pulmonary Arterial Hypertension (PAH), etc.) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 33 Aerosol Drug Delivery Devices Market: Distribution Channel Movement Analysis, 2018-2030 (USD Million)
  • Fig. 34 Aerosol Drug Delivery Devices Market Share Analysis by Distribution Channel, 2024 & 2030
  • Fig. 35 Retail Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 36 Institutional Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 37 Online Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 Aerosol Drug Delivery Devices Market Revenue, by Region, 2024 & 2030, (USD Million)
  • Fig. 39 Regional Marketplace: Key Takeaways
  • Fig. 40 North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
  • Fig. 46 Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 47 France Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 48 Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 49 Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 50 Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 51 Denmark Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 52 Norway Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
  • Fig. 53 Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 MEA Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key Company Categorization
  • Fig. 68 Company Market Positioning
  • Fig. 69 Key Company Market Share Analysis, 2024
  • Fig. 70 Strategic Framework